Skip to content

In the BioHarmony Drug Report Database


Apadaz (benzhydrocodone) is a small molecule pharmaceutical. Benzhydrocodone was first approved as Apadaz on 2018-02-23. It is used to treat pain in the USA. Apadaz's patents are valid until 2031-02-22 (FDA).
Trade Name Apadaz
Common Name Benzhydrocodone
Indication pain
Drug Class
Get full access now